Indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs)
Target
SSTR2 [HSA:6752] [KO:K04218]
Pathway
hsa04080
Neuroactive ligand-receptor interaction
hsa04935
Growth hormone synthesis, secretion and action
hsa04971
Gastric acid secretion
Brite
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Somatostatin
SSTR2
D11882 Copper Cu 64 dotatate <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11882
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11882